Drugs / PA5436 Ocular Implant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06964061 | Jun 2025 → Feb 2027 expected | ocular hypertension, open-angle glaucoma | PolyActiva Pty Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PA5436 Ocular Implant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06964061 ↗ |
| Route | Other | “administered into the intracameral space” NCT06964061 ↗ |